295 related articles for article (PubMed ID: 23868001)
1. Molecular sputum analysis for the diagnosis of lung cancer.
Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
[TBL] [Abstract][Full Text] [Related]
2. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
4. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
5. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
[TBL] [Abstract][Full Text] [Related]
6. Predicting lung cancer by detecting aberrant promoter methylation in sputum.
Palmisano WA; Divine KK; Saccomanno G; Gilliland FD; Baylin SB; Herman JG; Belinsky SA
Cancer Res; 2000 Nov; 60(21):5954-8. PubMed ID: 11085511
[TBL] [Abstract][Full Text] [Related]
7. Advances in sputum analysis for screening and early detection of lung cancer.
Tockman MS
Cancer Control; 2000; 7(1):19-24. PubMed ID: 10740657
[TBL] [Abstract][Full Text] [Related]
8. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
9. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
11. Sputum examination for early detection of lung cancer.
Thunnissen FB
J Clin Pathol; 2003 Nov; 56(11):805-10. PubMed ID: 14600122
[TBL] [Abstract][Full Text] [Related]
12. An update on sputum MicroRNAs in lung cancer diagnosis.
Sheervalilou R; Ansarin K; Fekri Aval S; Shirvaliloo S; Pilehvar-Soltanahmadi Y; Mohammadian M; Zarghami N
Diagn Cytopathol; 2016 May; 44(5):442-9. PubMed ID: 26865409
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
14. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of roentgenographically occult lung cancer by sputum cytology.
Petty TL; Tockman MS; Palcic B
Clin Chest Med; 2002 Mar; 23(1):59-64. PubMed ID: 11901920
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.
Machida EO; Brock MV; Hooker CM; Nakayama J; Ishida A; Amano J; Picchi MA; Belinsky SA; Herman JG; Taniguchi S; Baylin SB
Cancer Res; 2006 Jun; 66(12):6210-8. PubMed ID: 16778195
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Belinsky SA; Liechty KC; Gentry FD; Wolf HJ; Rogers J; Vu K; Haney J; Kennedy TC; Hirsch FR; Miller Y; Franklin WA; Herman JG; Baylin SB; Bunn PA; Byers T
Cancer Res; 2006 Mar; 66(6):3338-44. PubMed ID: 16540689
[TBL] [Abstract][Full Text] [Related]
18. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
19. TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
Liu WB; Han F; Huang YS; Chen HQ; Chen JP; Wang DD; Jiang X; Yin L; Cao J; Liu JY
Mol Carcinog; 2019 Apr; 58(4):474-487. PubMed ID: 30536447
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.
Gyoba J; Shan S; Roa W; Bédard EL
Int J Mol Sci; 2016 Apr; 17(4):494. PubMed ID: 27043555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
